Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Dynavax Technologies Corporation patents


Recent patent applications related to Dynavax Technologies Corporation. Dynavax Technologies Corporation is listed as an Agent/Assignee. Note: Dynavax Technologies Corporation may have other listings under different names/spellings. We're not affiliated with Dynavax Technologies Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dynavax Technologies Corporation-related inventors


Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung

The present disclosure relates to methods for treating cancer by intrapulmonary administration of a polynucleotide toll-like receptor 9 agonist. The methods of the present disclosure are suitable for treating primary cancer of the lung, as well as metastatic cancer to the lung and extra pulmonary cancers thereof. ... Dynavax Technologies Corporation

Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer

The present disclosure describes combination therapies comprising an antagonist of programmed death 1 receptor (pd-1) and a toll-like receptor 9 (tlr9) agonist that is a cpg-c type oligonucleotide, and the use of the combination therapies for the treatment of cancer.. . ... Dynavax Technologies Corporation

Combination of an anti-il-10 antibody and a cpg-c type oligonucleotide for treating cancer

The present disclosure describes combination therapies comprising an anti-il-10 antibody or antigen-binding fragment thereof and a cpg-c type oligonucleotide, and the use of the combination therapies for the treatment of cancer.. . ... Dynavax Technologies Corporation

Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer

The present disclosure relates to methods for treating cancer by intratumoral delivery of particles containing a toll-like receptor 9 agonist (tlr9) and a tumor antigen, in which the tlr9 agonist is a polynucleotide or a chimeric compound thereof. The methods of the present disclosure involve injection of the particles into at least one tumor, and are effective for treating both injected and uninjected tumors of a mammalian subject. ... Dynavax Technologies Corporation

Methods and compositions for eliciting an immune response against hepatitis b virus

The present invention relates to immunization of hypo-responsive groups of individuals. In particular, the present invention provides methods and compositions for eliciting a potent immune response to hepatitis b virus in individuals in need thereof.. ... Dynavax Technologies Corporation

Immunostimulatory sequence oligonucleotides and methods of using the same

The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.. . ... Dynavax Technologies Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dynavax Technologies Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dynavax Technologies Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###